The B. subtilis replicative polymerases bind the sliding clamp with different strengths to tune their activity in DNA replication
Luke G O’Neal, Madeline N Drucker, Ngoc Khanh Lai, Ashley F Clemente, Alyssa P Campbell, Lindsey E Way, Sinwoo Hong, Emily E Holmes, Sarah J Rancic, Nicholas Sawyer, Xindan Wang, Elizabeth S Thrall

TL;DR
This study explores how DNA polymerases in Bacillus subtilis interact with a protein called the sliding clamp to regulate DNA replication.
Contribution
The study reveals that two replicative polymerases in B. subtilis interact with the sliding clamp with different strengths, affecting their activity and mutagenesis.
Findings
PolC requires strong binding to the sliding clamp for efficient DNA replication.
DnaE interacts weakly with the clamp and its binding affects mutagenesis but not replication efficiency.
DnaE may act distributively but can be stabilized by clamp binding.
Abstract
Ring-shaped sliding clamp proteins are essential components of the replication machinery across all domains of life. DNA polymerases bind the clamp, increasing the processivity and rate of DNA synthesis. The current understanding of bacterial clamp-polymerase interactions was elucidated in Escherichia coli, which has one replicative polymerase. However, many bacteria have two essential replicative polymerases, such as PolC and DnaE in Bacillus subtilis. PolC performs the bulk of DNA synthesis whereas the error-prone DnaE only synthesizes short stretches of DNA, primarily on the lagging strand. Whether the clamp, DnaN, interacts with the two polymerases and coordinates their activity is unknown. We investigated this question by combining in vivo single-molecule fluorescence microscopy with biochemical and microbiological assays. We found that PolC–DnaN binding is essential, although…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6- —National Institute of General Medical Sciences of the National Institutes of Health
- —National Institute of Allergy and Infectious Diseases of the National Institutes of Health
- —National Science Foundation DBI Biology Integration Institutes Program
- —Camille and Henry Dreyfus Foundation Jean Dreyfus Lectureship
- —Fordham College
- —Fordham University Clare Boothe Luce
- —Fordham University Faculty Research
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDNA Repair Mechanisms · Bacterial Genetics and Biotechnology · Genomics and Chromatin Dynamics
Introduction
Cellular DNA is replicated by a multiprotein complex called the replisome, the basic features of which are conserved from bacteria to humans (Fig. 1A) [1–3]. A central component of the replisome is the replicative DNA helicase, which unwinds the parental double-stranded DNA (dsDNA) to generate single-stranded DNA (ssDNA). Another key component, the replicative DNA polymerase, catalyzes the synthesis of new DNA using the parental strands as templates. To synthesize the long stretches of DNA required to duplicate the genome, polymerases interact with sliding clamps, ring-shaped proteins that encircle the parental DNA and tether polymerases to the template [4–6]. DNA replication occurs by different mechanisms on the two parental DNA strands. On one, called the leading strand, the template DNA is oriented to allow continuous 5′–3′ synthesis of a new DNA strand. On the other, the lagging strand, synthesis occurs in short stretches of ∼1–2 kilobases (kb) in length, known as Okazaki fragments [1–3]. Transiently exposed ssDNA on the lagging strand is bound by another replisome component, single-stranded DNA-binding protein (SSB), which plays several roles in replication, including protecting ssDNA from degradation [7, 8]. Finally, because replicative DNA polymerases cannot synthesize DNA de novo, each Okazaki fragment is initiated by synthesis of a short RNA primer by an enzyme known as the primase [1–3].
PolC and DnaE bind DnaN with different affinities. (A) Cartoon of the Bacillus subtilis replisome. (B) AlphaFold predicted structures of B. subtilis DnaE (AlphaFold DB: AF-O34623-F1) and PolC (AlphaFold DB: AF-P13267-F1) with CBMs highlighted in red. See note on PolC structure in Supplementary Fig. S1. (C) Fluorescence polarization (FP) response for E. coli DnaN with tight-binding (QLSLPL) and binding-deficient (QADMA) CBM peptides. (D) FP response for B. subtilis DnaN with PolC (QLSLF), DnaE (QMGLF), and binding-deficient (AMGLA) CBM peptides. (E) FP response for B. subtilis DnaN with PolC (QLSLF) CBM peptides with flanking amino acids from PolC or DnaE. Fits to a 1:1 binding model are represented as solid lines. Error bars show standard deviation of at least three replicates.
The molecular mechanisms of bacterial DNA replication are best understood in the gram-negative species Escherichia coli. In E. coli, replication is performed by a single replicative polymerase, Pol III, which contains polymerase (α) and exonuclease (ϵ) subunits as well an accessory subunit (θ) [1, 3]. However, although the general replisome architecture is conserved across bacteria, it has become clear that there are key mechanistic differences in many species. In particular, many bacteria use more than one replicative polymerase [3, 9]. In low-GC gram-positive bacteria like the model organism B. subtilis, both polymerases PolC and DnaE are essential for DNA replication and cell viability [10–12]. It was initially proposed that PolC and DnaE were the leading- and lagging-strand polymerases, respectively, by analogy to the eukaryotic polymerases Pol ϵ and Pol δ [10]. However, the rate of synthesis for DnaE is too slow to support the rate of replication fork progression observed in vivo [11]. In the current model, DnaE extends the RNA primer upon replication initiation and at the start of each Okazaki fragment, only synthesizing a short stretch of DNA before yielding to PolC, which performs the bulk of the synthesis on both strands [11]. This model implies frequent exchange between DnaE and PolC, and it is unclear how the B. subtilis replisome coordinates the activity of the two polymerases.
Compared to most replicative DNA polymerases, DnaE has several unusual features. Unlike PolC, it does not contain an integral exonuclease domain, nor has it been found to interact with an accessory exonuclease [12, 13], analogous to the interaction between the α and ϵ subunits of E. coli Pol III. Thus, it is likely more error-prone than PolC. In the related low-GC gram-positive species Streptococcus pyogenes, the DnaE error rate was found to be two to three orders of magnitude higher than for E. coli Pol IIIα [14], and depletion of DnaE in B. subtilis was found to reduce ultraviolet (UV)-induced mutagenesis [13]. Further, DnaE has the ability to bypass certain DNA lesions [13, 14] and is modestly upregulated via the SOS DNA damage response, a transcriptional program that increases the expression of DNA repair and damage tolerance factors, suggesting a possible role in DNA repair or damage tolerance [13, 15].
To synthesize long stretches of DNA at high rates of ∼1000 base pairs (bp) per second, replicative DNA polymerases must interact with processivity factors known as sliding clamps. In bacteria, the clamp is a homodimer that contains two identical binding sites, one on each protomer, for polymerases and other interacting proteins [4–6]. A variety of DNA replication and repair proteins bind to the sliding clamp at these sites through short amino acids segments called clamp-binding motifs (CBMs). The most common CBM is a pentapeptide with the consensus sequence QL[S/D]LF or more generally QxxLF [12, 16]; studies in E. coli have found that mutations to the conserved residues (particularly at the first, fourth, and fifth positions) significantly weaken or abolish clamp-binding [16–18]. Typical dissociation constants (KD) for the clamp-binding interaction in E. coli range from 100 nM to 1 μM.
Like all DNA polymerases in E. coli, both replicative polymerases in B. subtilis have canonical CBMs situated to allow clamp binding (Fig. 1B and Supplementary Fig. S1). The PolC CBM (QLSLF) is located at the protein C-terminus and is more conserved than the internal DnaE CBM (QMGLF). Given the presence of conserved CBMs, it is reasonable to assume that both PolC and DnaE interact with the clamp during replication. However, polymerase-clamp interactions in B. subtilis have never been quantified and the binding affinities are unknown. There is indirect evidence for PolC–DnaN binding in the form of a yeast two-hybrid assay [19], and biochemical studies have shown that PolC activity is stimulated by the interaction with the clamp [20]. For DnaE, however, the results are conflicting. The same yeast two-hybrid assay did not find evidence for a DnaE–DnaN interaction [19]. Several biochemical studies have suggested that the presence of the clamp affects either the processivity or the rate of synthesis of DnaE, although indirect effects cannot be excluded due to the presence of other replisome components in the assays [11, 20, 21]. Indeed, there is evidence for DnaE interactions with other replisome components, including SSB [21, 22], the clamp-loader complex subunit δ (HolA) [23], and a complex formed by the helicase DnaC and primase DnaG [23].
In this study, we investigate the interaction between DnaN and the replicative polymerases PolC and DnaE in B. subtilis. We find that deleting the PolC CBM or mutating it to eliminate clamp-binding is lethal, but weakening the PolC–DnaN interaction by an order of magnitude is tolerated, though it leads to defects in DNA replication and changes in PolC cellular localization. Further, we show that DnaE also binds the clamp, albeit roughly 20-fold less tightly than PolC. Surprisingly, however, the DnaE–DnaN interaction is dispensable for DNA replication. Eliminating clamp-binding in DnaE has no effect on DNA replication, damage tolerance, or mutagenesis, nor does it alter the cellular localization and dynamics of DnaE. Strengthening the DnaE–DnaN interaction also has no effect on DNA replication or damage tolerance, but it leads to an increase in damage-induced mutagenesis and subtle changes in DnaE cellular localization and dynamics. These results provide new insights into protein-protein interactions in the B. subtilis replisome and the role of the sliding clamp in polymerase coordination in bacteria.
Materials and methods
Bacterial strain and plasmid construction
Plasmids were constructed by amplifying dsDNA fragments using polymerase chain reaction (PCR), joining fragments by Gibson assembly [24], and transforming them into the cloning strain E. coli DH5α. Transformants were streak-purified once and then plasmids were miniprepped and validated by whole-plasmid sequencing. All B. subtilis strains were constructed in the wild-type (WT) PY79 background. All genetic modifications were introduced at the endogenous chromosomal loci unless noted otherwise. New genetic modifications were created by transformation of dsDNA fragments amplified by PCR and joined by Gibson assembly. Genetic modifications were transferred between strains by transformation of genomic DNA. Genetic modifications were linked to antibiotic resistance cassettes and transformants were selected on plates containing the corresponding antibiotic. Modified genetic loci were validated by diagnostic PCR and Sanger DNA sequencing. All oligonucleotides, plasmids, and bacterial strains used in this study are listed in Supplementary Tables S1–S3.
Protein expression and purification
pET-28b plasmids expressing N-terminally hexahistidine (His_6_)-tagged E. coli and B. subtilis DnaN were transformed into E. coli BL21(DE3). Large-scale (500 ml) LB Miller cultures were inoculated and grown at 37°C shaking at 225 rpm until the optical density at 600 nm (OD_600nm_) reached 0.6–0.9, induced by addition of 1 mM isopropyl β-d-1-thiogalactopyranoside, and grown for an additional 3 h under the same conditions. Cell pellets were harvested by centrifugation at 6079 × g for 15 min at 4°C and stored at −80°C until resuspension for purification. Pellets were resdissolved in lysis buffer [20 mM Tris–HCl (pH 7.5), 350 mM NaCl, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mM imidazole, 5 mM β-mercaptoethanol (BME), and 1 mg ml^−1^ lysozyme] at 5 ml/g concentration and incubated at 4°C for 30 min, followed by sonication (Fisherbrand Model 120; 2–4 30 s cycles at 60% intensity with bursts of 1 s on and 1 s off). The lysate was cleared by centrifugation at 18 138 × g for 1 h at 4°C. Imidazole was added to a final concentration of 30 mM and then the cleared lysate was incubated with Ni-NTA agarose (Thermo Scientific, HisPur resin; 2 ml bed volume) for 1 h at 4°C. After allowing the lysate to flow through, the column was washed sequentially with a high-salt buffer [20 mM Tris–HCl (pH 7.5), 500 mM NaCl, 5 mM BME, 1 mM PMSF, and 30 mM imidazole] and a low-salt buffer [20 mM Tris–HCl (pH 7.5), 100 mM NaCl, 5 mM BME, 1 mM PMSF, and 30 mM imidazole]. Bound protein was eluted in stages with elution buffer [20 mM Tris–HCl (pH 7.5), 100 mM NaCl, 5 mM BME, and 150 mM imidazole]. Fractions containing the protein were pooled and dialyzed overnight against dialysis buffer [20 mM Tris–HCl (pH 7.5), 100 mM NaCl, 5 mM BME, and 10% glycerol]. The dialyzed solution was concentrated using a spin concentrator (Amicon Ultra-4 10 000 MWCO) by centrifugation at 4000 × g at 4°C. The protein concentration was quantified spectrophotometrically by measuring the absorbance at 280 nm (A280nm) using a microvolume spectrophotometer (DeNovix DS-11FX) and converting to concentration using extinction coefficients from the ExPASY ProtParam tool (ϵ_280nm_ = 15 930 M^−1^ cm^−1^ and 14 440 M^−1^ cm^−1^ for E. coli and B. subtilis DnaN, respectively). Protein purity was assessed by sodium dodecyl sulfate–polyacrylamide gel electrophoresis. Protein stocks were aliquoted, flash frozen in liquid nitrogen, and stored at −80°C until use.
For validation of results obtained with our own purified protein, because we were surprised by the lower-than-expected binding affinities, we purchased a custom batch of N-terminally His_6_-tagged B. subtilis DnaN from a commercial source (GenScript). This protein contained the same amino acid sequence, including the His_6_ tag and short linker, as our own construct. Unless noted otherwise, binding assays were performed with this batch of protein.
Peptide synthesis
Commercially purchased solvents and reagents were used without further purification. Nα-Fmoc-protected amino acids and peptide synthesis reagents were purchased from Advanced ChemTech, ChemImpex International, Oakwood Chemical, and Gyros Protein Technologies. Peptides were synthesized manually or using a Gyros Protein Technologies PurePep^TM^ Chorus synthesizer. Peptides were synthesized following standard Fmoc solid-phase approaches on either high-loading Rink MBHA resin (0.62 mmol/g resin) or Wang resin pre-loaded with Fmoc-phenylalanine (0.35 mmol/g). For solid-phase fluorescein labeling of the E. coli-derived peptides (QLSLPL and QADMA), five equivalents each of fluorescein isothiocyanate and N,N’-diisopropylethylamine in N,N-dimethylformamide (DMF) were added to the peptide after removal of the final Fmoc protecting group. For solid-phase fluorescein labeling of the *B. subtilis-*derived peptides (QLSLF, QMGLF, and AMGLA), five equivalents each of 5(6)-carboxyfluorescein, ethyl cyanohydroxyiminoacetate (Oxyma), and N,N’-diisopropylcarbodiimide were added to DMF for 20 min for pre-activation and then added to the peptide after removal of the final Fmoc protecting group and reacted overnight. Peptides were globally deprotected and cleaved from resin by incubation with Reagent R [90% trifluoroacetic acid (TFA), 5% thioanisole, 3% 1,2-ethanedithiol, and 2% anisole] for 2 h. After filtration through a cotton plug, rotary evaporation of TFA and precipitation with ice-cold diethyl ether yielded crude peptides. Peptides were purified on preparative C_18_ columns using reverse-phase high-performance liquid chromatography (RP-HPLC) on a Shimadzu Nexera HPLC system using gradients of water and acetonitrile (ACN) containing 0.1% TFA. Peptide purity was evaluated by mass spectrometry (Supplementary Table S4) and analytical HPLC (Supplementary Fig. S2) using a Luna 5 μm C18(2) column (150 × 4.6 mm) on an Agilent 1100 HPLC system with a flow rate of 0.3 ml min^−1^ (gradient: 5%–95% solvent B over 30 min, solvent A = 0.1% TFA, B = 95% ACN, 5% water, 0.1% TFA).
FP-binding measurements
Binding affinities were determined using FP assays with fluorescein-tagged peptides and purified DnaN proteins. Proteins were thawed on ice and diluted in the same dialysis buffer used for purification, supplemented with 0.1% pluronic acid F-68. Stock solutions of fluorescent peptides were prepared by dissolving peptides in 10 mM sodium phosphate buffer (pH 7.4) supplemented with 0.1% pluronic acid F-68 to a concentration of 2 μM (100 × the final assay concentration of 20 nM).
For each assay, a volume of 225 μl of protein was diluted in the supplemented dialysis buffer to the maximum concentration (10 μM for E. coli DnaN, 50 μM for B. subtilis DnaN) and used to prepare a 3-fold serial dilution (150 μl per dilution). For each protein dilution, a 1.5 μl volume of fluorescent peptide was added such that the final peptide concentration was 20 nM. Negative control samples were prepared by diluting 1.5 μl of fluorescent peptide into 150 μl of dialysis buffer supplemented with 0.1% pluronic acid F-68. Each sample was then divided into three wells of a black 96-well plate (50 μl/well).
Data were collected on a BioTek Synergy H1M plate reader equipped with polarization filters (excitation: 485/20 nm, emission: 528/20 nm) using the FP program within the Gen5 software (version 3.08). Data were exported and fit to a 1:1 binding model accounting for the presence of both free and bound protein according to the following equation:
\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{upgreek} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*} FP = A\frac{{\left( {{{{\left[ R \right]}}_{{\rm total}}} + {{{\left[ P \right]}}_{{\rm total}}} + {{K}_{\rm D}}} \right) - \sqrt {{{{\left( {{{{\left[ R \right]}}_{{\rm total}}} + {{{\left[ P \right]}}_{total}} + {{K}_{\rm D}}} \right)}}^2} - 4 \times {{{\left[ R \right]}}_{{\rm total}}} \times {{{\left[ P \right]}}_{{\rm total}}}} }}{{2 \times {{{\left[ R \right]}}_{{\rm total}}}}} + B, \end{equation*}\end{document}where A is the amplitude (maximum FP response), B is the baseline (minimum FP response), [R]total is the peptide concentration (in μM), and [P]total is the protein concentration (in μM) [25].
Growth curve measurements
Liquid cultures were grown in LB Lennox and S7_50_-sorbitol media at 25 ml scale following the same approach reported previously for imaging culture growth [26]. OD_600nm_ was measured using a 1:1 dilution of growth curve sample in fresh media. Measurements were taken hourly until the cells entered early exponential phase, which took ∼2 h in LB Lennox media and 3 h in S7_50_-sorbitol media, respectively. From then onward, OD_600nm_ was measured every half hour until the cells reached stationary phase. Growth rates and doubling times were determined via a linear fit to the exponential phase of the growth curves.
Spot dilution growth assays
Liquid cultures were grown in LB Lennox and S7_50_-sorbitol media at 25 ml scale following the same approach described for growth curve measurements. LB Lennox and S7_50_-sorbitol agar plates were freshly prepared with 1.5% agar on the day of spotting. When cultures reached OD_600nm_ ≈ 0.3, cell concentrations were normalized to OD_600nm_ = 0.2. These samples were then serially diluted 10-fold in media down to OD_600nm_ = 2 × 10^−6^. A 5 μl volume of each dilution was spotted on the agar plates. Images of the plates were recorded after ∼16 h incubation at 37°C.
Marker frequency analysis and whole-genome sequencing
Cultures were grown in S7_50_-sorbitol or LB Lennox media at 25 ml scale following the same approach described for growth curve measurements. When cultures reached OD_600nm_ ≈ 0.15, cells were harvested and concentrated by centrifugation in a series of steps at room temperature: first 10 min at 10 000 × g, then 5 min in a Fisher Scientific Centrific 225 Centrifuge on power level 8.5, and finally 3 min at 16 000 × g to remove all the supernatant. Cell pellets were flash frozen in liquid nitrogen and stored at −80°C until use. Genomic DNA was extracted using the Qiagen DNeasy blood and tissue kit (catalog #69504; Qiagen). DNA was sonicated using a Qsonica Q800L sonicator for 12 min at 20% amplitude to achieve an average fragment size of 170 bp. A DNA library was prepared using the NEBNext Ultra II kit (E7645; New England Biolabs) and sequenced using Illumina Nextseq2000. Sequencing reads were mapped to the B. subtilis PY79 genome (NCBI reference sequence NC_022898.1) using CLC Genomics Workbench (Qiagen). The mapped reads were normalized to the total number of reads and plotted in 10-kb bins using R.
DNA damage survival assays
Cell survival assays with 4-nitroquinoline 1-oxide (4-NQO) were performed as described previously [26]. In brief, exponentially growing cultures in 3 ml LB Lennox media were serially diluted and spread on LB Lennox agar plates containing different 4-NQO concentrations (0, 0.05, 0.075, or 0.1 μM). Plates were incubated overnight at 37°C, colonies were enumerated, and the survival rate relative to the no drug plate was calculated. At least three independent experimental replicates were performed for each strain.
To assay survival to UV light, cells were cultured in LB Lennox media following the same approach as for 4-NQO survival assays. Cultures were serially diluted and spread on plain LB Lennox agar plates, then irradiated with different dosages (0, 10, 20, or 40 J m^−2^) of 254 nm UV light (Analytik Jena UVS-28 EL). Plates were incubated overnight, and survival rates were calculated as above. At least three independent experimental replicates were performed for each strain.
Rifampicin resistance mutagenesis assays
Spontaneous and UV-induced mutagenesis was assayed by measuring the rate of rifampicin resistance. Cultures were grown in LB Lennox media following a similar approach as for survival assays. Fresh cultures were prepared at 10 ml scale and incubated for 3.5 h, then pelleted by centrifugation in a Fisher Scientific Centrific Centrifuge on power level 8.5 for 5 min. Cell pellets were resuspended in 50 ml of 10 mM MgSO_4_. The resulting 50 ml solution was divided into two halves, one of which was not treated and one of which was irradiated with 254 nm UV light at a dose of 40 J m^−2^. Cells were pelleted by centrifugation in two stages, first at 10 000 × g for 6 min and then in a Fisher Scientific Centrific Centrifuge as on power level 8.5 for 5 min. Cell pellets were resuspended in 10 ml LB Lennox media and incubated overnight for 22–24 h at 37°C shaking at 225 rpm. The following morning, LB Lennox agar plates were freshly prepared either with or without 10 μg ml^−1^ rifampicin (by a 1:1000 dilution of a rifampicin stock in dimethylsulfoxide). Cultures were concentrated by centrifugation as described previously to OD_600nm_ ≈ 20 and spread on Rif^+^ plates. Concentrated cultures were serially diluted to OD_600nm_ ≈ 10^−5^ and spread on Rif^−^ plates. Colonies were enumerated after overnight incubation at 37°C. Mutation rates were determined by normalizing the number of colony-forming units (CFUs) per ml on Rif^+^ plates by the number on Rif^−^ plates. At least five independent experimental replicates were performed for each strain.
Cell culture and sample preparation for microscopy
Samples were prepared for microscopy exactly as described previously [26]. In brief, cultures were grown in S7_50_-sorbitol minimal medium until early exponential phase (OD_600nm_ ≈ 0.1–0.2), then aliquots were harvested and sparsely labeled with Janelia Fluor X 554 (JFX_554_) HaloTag ligand at 1 nM final concentration for Halo-DnaE and 500 pM final concentration for PolC-Halo for 15 min at 37°C and shaking at 225 rpm. Samples were washed by resuspension in S7_50_-sorbitol media to remove free dye and concentrated by centrifugation, then deposited on pads prepared from 3% agarose (NuSieve) dissolved in media. Pads were sandwiched between cleaned coverslips and imaged immediately.
Microscopy
Microscopy was performed using a custom fluorescence microscope described in detail previously [26]. In brief, an inverted microscope (Nikon Ti2-E) was equipped with a Nikon CFI Apo 100×/1.49 NA total internal reflection fluorescence (TIRF) objective lens, a Hamamatsu ImageEM C9100-23BKIT EMCCD camera, and Chroma filters. Highly inclined thin illumination [27], or near-TIRF, excitation was provided by focusing 514 nm and 561 nm lasers (Coherent Sapphire) to the objective back focal plane (BFP) and translating the beams away from the BFP optical axis. Excitation sequences were automated with computer-controlled shutters (Vincent Uniblitz) and a computer-controlled stage (Mad City Labs) was used for translation between fields of view. White light transillumination was used to record brightfield images of cells.
A short integration time (13.9 ms) was used in all imaging experiments, allowing the detection of both static and mobile Halo-DnaE and PolC-Halo molecules. JFX_554_-labeled HaloTag fusions were imaged using a 561 nm laser power density of ∼15 W cm^−2^ at the sample. To visualize DnaX-mYPet foci, 100 frames of 514 nm excitation were recorded at the start of each movie at ∼1 W cm^−2^ power density. Imaging of PolC-mYPet foci used a 514 nm laser power density of ∼5 mW cm^−2^.
Image analysis
Image analysis was performed using the MATLAB-based packages MicrobeTracker [28] (for segmentation of brightfield images) and u-track [29, 30] (for single-particle detection and tracking), in addition to custom MATLAB code. The analysis approach was described in detail previously and the same analysis parameters were used [26]. As described previously, the first 20 frames of 561 nm excitation were averaged for u-track analysis of DnaX-mYPet and PolC-mYPet foci.
Data analysis
Analysis of Halo-DnaE and PolC-Halo diffusion in short-exposure movies was performed exactly as described before by calculating an apparent diffusion coefficient D* from the mean squared displacement (MSD) [26]; as an alternative approach, diffusion was also analyzed with the analysis package Spot-On [31] with the same analysis parameters used previously [26]. Analysis of the average cellular localization of DnaX-mYPet and PolC-mYPet foci was likewise performed exactly following prior methods, as was radial distribution function analysis to quantify colocalization between Halo-DnaE or PolC-Halo molecules and DnaX-mYPet foci [26].
Imaging dataset
Imaging datasets for main experimental results consisted of at least three biological replicates (separate imaging cultures) collected on at least two different days; for some control experiments, two replicates on separate days were collected. The number of imaging days, replicates, cells, and tracks or foci for all figures are listed in Supplementary Table S5.
Polymerase CBM sequence analysis
CBM sequence data for bacterial species in the Firmicutes phylum were obtained from the representative polymerase dataset (Supplementary Table S1 from Timinskas et al.) [12]. The data were sorted first by phylum and then by polymerase group. After isolating the Firmicutes data, entries missing Organism or CBM fields were removed. Data for the PolC (n = 173), DnaE1 (n = 81), and DnaE3 (n = 86) groups were converted to FASTA format and aligned using the MUSCLE algorithm in SnapGene (v. 8.0.3).
Results
Both the PolC and DnaE CBMs bind the clamp, but the DnaE CBM binds more weakly
Although PolC and DnaE contain canonical CBMs, no studies have quantitatively characterized their interaction with the clamp, DnaN. Previous studies in E. coli have shown that peptide CBMs are able to recapitulate clamp-binding using FP [32, 33], surface plasmon resonance [17, 34], or isothermal titration calorimetry [33, 34]. Thus, we implemented an FP binding assay using purified DnaN and short peptides containing CBM sequences labeled with fluorescein (Supplementary Fig. S2 and Supplementary Table S4). Similar to prior reports, we designed each peptide with 2–3 flanking amino acid residues from the native polymerase sequence on either end of the CBM as well as a 6-aminohexanoic acid residue linker and fluorescein appended to the N-terminus.
We first showed that we could reproduce prior clamp-binding measurements using purified E. coli DnaN (Fig. 1C). We tested the binding of two well-characterized peptides from a previous study, one with a tight-binding CBM from the Hda protein (QLSLPL) and one with a binding-deficient CBM (QADMA), in which the terminal phenylalanine of the Pol IIIα CBM (QADMF) is mutated to alanine [17]. In a direct binding format, increasing concentrations of DnaN are incubated with a fixed concentration of fluorescently labeled peptide and the FP response is measured. As expected, the tight-binding CBM binds to the clamp, showing a characteristic sigmoidal profile (Fig. 1C). We fit the FP response versus DnaN concentration to a 1:1 binding model to determine the dissociation constant, KD; although the dimeric clamp contains two equivalent binding sites, previous studies have used a 1:1 Langmuir model [17, 34]. Consistent with prior reports [17, 35], we found that the tight-binding peptide binds E. coli DnaN with a sub-micromolar dissociation constant (mean ± std. dev.: KD = 280 ± 90 nM), validating our FP assay design. As expected, the binding-deficient peptide showed no measurable binding up to a DnaN concentration of 10 μM (Fig. 1C).
Next, we tested the binding of the WT PolC and DnaE CBM peptides to the B. subtilis clamp. Because the PolC CBM is located at the C-terminal end of the protein, this peptide was terminated with a carboxylic acid, rather than an amide, to match its context in the protein. Although we found that both CBM peptides bound the clamp, they did so with much lower affinity (Fig. 1D). For the PolC CBM peptide, we measured KD = 3.8 ± 1.8 μM, ∼5-fold weaker than binding of the same CBM sequence to the E. coli clamp [17]. Although the DnaE CBM peptide also bound the clamp, it did so even more weakly than PolC, despite matching the consensus QxxLF motif. We did not test DnaN concentrations higher than 50 μM, but a fit to the data provided an approximate value of KD = 78 ± 39 μM, ∼20-fold weaker than PolC CBM binding and two orders of magnitude weaker than the binding of strong CBM sequences in E. coli. To test whether the measured binding was specific, we created a mutant DnaE CBM peptide with the highly conserved first and fifth residues mutated to alanine (AMGLA). Consistent with studies in E. coli, which found that mutating these residues substantially weakened binding [16, 17], this double alanine DnaE CBM mutant showed minimal binding up to a DnaN concentration of 50 μM. Taken together, our measurements indicate that both PolC and DnaE can bind the B. subtilis clamp via their CBMs, albeit with significantly different affinities.
The PolC–DnaN interaction is essential, but the DnaE–DnaN interaction is not
To examine whether the clamp interaction was essential for DNA replication, we first tested whether the PolC CBM could be eliminated or mutated by attempting to modify the polC gene. Because the PolC CBM is the last five amino acids at the C-terminus of the protein, we tried to truncate it. Despite multiple attempts, we were unable to recover transformants containing the truncation mutation, suggesting that the presence of the PolC CBM is essential. Consistent with the lack of binding observed for the AMGLA CBM peptide in the FP assays, we were likewise unable to recover transformants in which the PolC CBM was altered to AMGLA. Surprisingly, however, a PolC mutant (polC^QMGLF^) bearing the WT DnaE CBM, QMGLF, was viable, despite the CBM sequence having ∼20-fold lower affinity for the clamp than the WT PolC CBM. These results indicate that the PolC–DnaN interaction is essential to replication, but a significantly weaker clamp-binding interaction than the WT interaction still permits polymerase function.
Next, we tested whether the DnaE–DnaN interaction was likewise essential for DNA replication. Because the DnaE CBM is internal, we did not attempt to delete it; instead, we introduced the double-alanine AMGLA mutation, which was deficient in clamp binding in FP assays. Surprisingly, we found that a strain bearing this mutation (dnaE^AMGLA^) was viable. Thus, the DnaE–DnaN interaction is dispensable for DNA replication, in contrast to the essentiality of the PolC–DnaN interaction. In light of these results, we asked whether strengthening the DnaE–DnaN interaction would prove lethal by allowing DnaE to compete more effectively with PolC for clamp binding; given the much slower rate of synthesis of DnaE, even partial replacement of PolC in the replisome could have substantial effects on replication and thus viability. To test this question, we created a strain in which the DnaE CBM was mutated to the WT PolC CBM sequence QLSLF (dnaE^QLSLF^); binding of this PolC CBM sequence with the flanking amino acids from DnaE to DnaN was similar to its binding in the native PolC context (KD = 7.2 ± 2.2 μM) (Fig. 1E). We found that a strain bearing the dnaE^QLSLF^ mutation was viable, indicating that PolC could still gain access to the clamp in the presence of the tight-binding DnaE CBM mutant.
Altering the DnaE–DnaN interaction does not affect cell growth or DNA replication, but altering the PolC–DnaN interaction does
After identifying mutations in the PolC and DnaE CBMs that were tolerated in vivo, even though the polC and dnaE genes themselves are essential, we next characterized the impact of these mutations on cell growth and DNA replication. First, we measured growth curves of the WT and CBM mutant strains in liquid culture. For growth in minimal S7_50_-sorbitol media, the WT strain has a doubling time of 60 ± 1 min (mean ± std. dev.) in exponential phase (Fig. 2A and Supplementary Table S6). We found no change in growth rate for the binding-deficient dnaE^AMGLA^ mutant and the tight-binding dnaE^QLSLF^ mutant (58 ± 1 min and 59.1 ± 0.6 min, respectively; P >.05 versus WT); the same was true for the polC^QMGLF^ mutant (58 ± 2 min; P >.05). Reasoning that DNA replication defects might become more apparent in rich media, with faster cell growth, we also quantified the growth rate in LB Lennox media. Under these conditions, the WT doubling time is 31 ± 1 min (Fig. 2B and Supplementary Table S6). The dnaE^QLSLF^ mutant was still indistinguishable from WT (30 ± 1 min; P >.05). Although the dnaE^AMGLA^ doubling time was statistically distinguishable from WT, the change was minimal (28 ± 2 min; P <.05). However, the polC^QMGLF^ mutant displayed a clear growth defect with a doubling time (41 ± 3 min; P <.05) that was 30% longer than WT.
Growth and replication characterization of WT and CBM mutant DnaE and PolC strains. Liquid culture growth curves for WT, dnaEAMGLA, dnaEQLSLF, and polCQMGLF strains in (A) S750-sorbitol and (B) LB Lennox media. Error bars show standard deviation of at least three replicates. Serial dilutions for WT, dnaEAMGLA, dnaEQLSLF, polCQMGLF, and ssb Δ35 strains on (C) S750-sorbitol and (D) LB Lennox agar media. Images are representative of at least two consistent replicates. Whole-genome sequencing (WGS) analysis showing the normalized number of reads versus genome location for WT, dnaEAMGLA, dnaEQLSLF, polCQMGLF, and ssb Δ35 strains in (E) S750-sorbitol and (F) LB Lennox media. Plotted data are averages of two independent replicates.
Because cell growth differs in liquid and solid media, we also characterized growth of the WT and CBM mutant strains on solid media. Cells were harvested from liquid cultures, serially diluted, spotted on agar plates containing media, and incubated overnight. The plates were analyzed qualitatively for differences in colony number and size. Consistent with the liquid culture growth curve results, growth of the DnaE and PolC CBM mutant strains was indistinguishable from that of the WT strain on minimal S7_50_-sorbitol agar (Fig. 2C). Likewise, on rich LB Lennox agar, the DnaE CBM mutant strain growth was identical to WT (Fig. 2D). Although the PolC CBM mutant strain did not have a viability defect, it displayed a spiky colony morphology. Because we did not observe a viability defect for any of the CBM mutant strains, we also tested a strain that was known to be significantly impaired in growth. This strain (ssb Δ35) bears a 35 amino acid truncation to the C-terminal of the replisome component SSB. Deletion of the SSB C-terminal tail was reported to confer substantial DNA replication and cell morphology defects [22]. Consistent with this prior report, we found that viability of the ssb Δ35 strain was reduced by roughly one or two orders of magnitude relative to WT in S7_50_-sorbitol and LB Lennox media, respectively, confirming that a substantial viability defect would be evident in these assays. Taken together with the liquid culture growth curves, these results indicate that DNA replication is moderately impaired when the PolC–DnaN interaction strength is reduced, although this effect is only obvious for fast growth in rich media. Surprisingly, however, we found no evidence that eliminating the DnaE–DnaN interaction alters cell growth.
To determine whether altering the DnaE–DnaN interaction led to DNA replication defects not apparent in growth assays, we analyzed genome-wide DNA replication profiles using marker frequency analysis (MFA) of WGS results. Cultures were grown in S7_50_-sorbitol or LB Lennox media to early exponential phase, then cells were harvested and lysed. WGS was performed, and the number of sequencing reads was plotted as a function of chromosomal position. Because replication initiates at the chromosomal origin (ori) and concludes at the terminus (ter), the DNA content and therefore relative number of reads is highest at ori and decays toward ter. Defects in DNA replication lead to changes in the DNA content profile and the ratio of ori:ter reads can be used as a single quantitative metric [36, 37]. As expected, the ssb Δ35 mutant had an altered replication profile and elevated ori:ter ratio relative to WT in both S7_50_-sorbitol and LB Lennox media (Fig. 2E and F, Supplementary Fig. S3, and Supplementary Table S7), consistent with a slowdown of replication [21, 37]. However, we found that the binding-deficient dnaE^AMGLA^ mutant and the tight-binding dnaE^QLSLF^ mutant had essentially the same replication profiles as the WT strain in both growth media; the polC^QMGLF^ mutant only showed altered replication profile under fast-growth conditions (LB Lennox media), with an elevated ori:ter ratio consistent with an elongation defect. Thus, altering the DnaE–DnaN interaction does not affect DNA replication, but altering the PolC–DnaN interaction slows down DNA replication.
Strengthening the DnaE–DnaN interaction promotes damage-induced mutagenesis
Unusually for a replicative polymerase, DnaE is a member of the SOS regulon and is modestly upregulated upon DNA damage [13, 15]. It lacks an integral proofreading domain [12], and no accessory proofreading subunit, analogous to E. coli Pol IIIϵ, has been identified. Thus, it is more error-prone than E. coli Pol III and has also been shown to bypass certain DNA lesions more efficiently [13, 14, 20]. We therefore asked whether the clamp interaction might play a role in the response of DnaE to DNA damage.
First, we determined whether the DnaE–DnaN interaction had an effect on cell survival upon DNA damage. We tested two different DNA damaging agents, 4-NQO and 254-nm UV light. 4-NQO generates various adenine and guanine lesions, particularly quinoline N^2^-dG adducts [38–40], whereas short-wavelength UV-C light produces several highly blocking lesions, including cyclobutane pyrimidine dimers and 6-4 photoproducts [41]. Consistent with prior reports [26, 42], we found that a strain lacking the translesion synthesis polymerase Pol Y1 (ΔyqjH) was sensitized to both 4-NQO and UV treatment relative to the WT strain (Fig. 3A and B). In contrast, both the binding-deficient dnaE^AMGLA^ mutant and the tight-binding dnaE^QLSLF^ mutant had WT levels of resistance to both types of DNA damage. Although these results do not exclude the possibility that an effect would be observed for other types of DNA lesions, they suggest that any involvement of DnaE in the DNA damage response does not require an interaction with the clamp, nor is it enhanced by a stronger clamp-binding interaction.
Relative survival and mutagenesis of WT and CBM mutant DnaE strains. (A) Relative survival of WT, dnaEAMGLA dnaEQLSLF, and Pol Y1 knockout strains treated with different concentrations of 4-NQO. (B) Relative survival of WT, dnaEAMGLA, dnaEQLSLF, and Pol Y1 knockout strains treated with different doses of 254 nm UV light. For panels (A) and (B), error bars show standard deviation of at least three replicates. (C) Proportion of rifampicin resistant (RifR) cells for WT, dnaEAMGLA, and dnaEQLSLF strains in untreated cells and cells treated with 40 J m−2 254 nm UV light. For each dataset, the individual replicates are shown as circles, the red line represents the mean value, and the error bars represent the standard deviation of at least five replicates.
Given the prior finding that DnaE contributes to UV-induced mutagenesis [13], we next asked whether the DnaN interaction plays a role in mutagenesis. We measured the rate of resistance to a 10 μg ml^−1^ concentration of the drug rifampicin (Rif^R^) both in untreated cells and in cells treated with a 40 J m^−2^ dose of 254 nm UV light. This concentration of rifampicin is generally lethal, but mutations in the β-subunit of RNA polymerase (rpoB) can confer resistance [43, 44], providing a proxy for the overall genomic mutation rate. In agreement with prior reports [13, 26, 45], the spontaneous Rif^R^ mutation rate for the WT strain was ∼1/10^8^ cells (Fig. 3C and Supplementary Table S8). UV treatment increased this rate by ∼20-fold (P <.05), again consistent with previous results. Both the dnaE^AMGLA^ and dnaE^QLSLF^ mutants had similar spontaneous mutation rates to WT (P >.05). However, the tight-binding dnaE^QLSLF^ mutant had a 3-fold higher UV-induced mutation rate than the WT strain (P <.05). Although dnaE^AMGLA^ showed a more modest increase in mutation rate relative to WT, the difference was not statistically significant (P >.05). These results support a model in which strengthening the DnaE–DnaN interaction allows DnaE to gain increased access to the DNA template upon perturbations to replication, increasing the mutation rate due to its error-prone activity.
Altering the DnaN interaction has subtle effects on DnaE and PolC localization and dynamics in vivo
Taken together, our results support a model in which the PolC–DnaN interaction is essential for DNA replication; a binding affinity reduction of roughly 20-fold is tolerated, albeit with a growth defect in rich media. Although the DnaE–DnaN interaction is dispensable for replication and has no apparent effect on growth under any conditions tested, strengthening the interaction promotes mutagenesis, presumably by enhancing the access of DnaE to the DNA template. Next, we asked whether altering the clamp interaction had an effect on PolC and DnaE localization and dynamics in the cell using in vivo single-molecule fluorescence microscopy.
We created and validated an N-terminal fusion of the endogenous copy of DnaE to the self-labeling HaloTag (Halo) [46]; we introduced an N-terminal tag because we had found previously that C-terminal fusions to the yellow fluorescent protein variant mYPet [47] were impaired in growth, whereas N-terminal fusions were not (Supplementary Fig. S4B and Supplementary Table S9). In addition to the Halo-DnaE fusion, we introduced a C-terminal mYPet fusion to the endogenous copy of the clamp-loader complex subunit DnaX to serve as a marker for replication sites in the cell (Fig. 4A and B) [26, 48, 49]. Growth curve measurements indicated that the Halo-DnaE fusion in combination with the DnaX-mYPet fusion had no effect on growth rate in the S7_50_-sorbitol media used for imaging (Supplementary Fig. S4A and Supplementary Table S9), indicating that the fusions are functional. In addition, we were able to construct the corresponding binding-deficient Halo-DnaE^AMGLA^ and tight-binding Halo-DnaE^QLSLF^ fusions and combine them with DnaX-mYPet.
Imaging of single Halo-DnaE and PolC-Halo molecules. Representative micrographs of (A) Halo-DnaEQMGLF(WT) with endogenous DnaX-mYPet fusion and (B) PolCQLSLF(WT)-Halo with ectopic DnaX-mYPet fusion. Left: Transmitted white light micrograph of B. subtilis cell with overlaid cell outline and 1-μm scale bar. Middle: Fluorescence micrograph of single Halo-DnaEQMGLF(WT)-JFX554 or PolCQLSLF(WT)-Halo-JFX554 molecule with overlaid trajectory. Right: Fluorescence micrograph of DnaX-mYPet foci with overlaid centroids. (C) Apparent diffusion coefficient (D) distributions and corresponding three-population fits for Halo-DnaEQMGLF(WT), Halo-DnaEAMGLA, Halo-DnaEQLSLF, and PolCQLSLF(WT)-Halo. (D) Radial distribution function g(r) analysis of Halo-DnaE or PolC-Halo colocalization with DnaX-mYPet. Left: Halo-DnaEQMGLF(WT) and PolCQLSLF(WT)-Halo. Right: Halo-DnaEQMGLF(WT), Halo-DnaEAMGLA, and Halo-DnaEQLSLF. Random g(r) curves are shown as dashed lines. g(r) values > 1 indicate colocalization relative to chance. The plotted data represent at least three independent replicates (see Supplementary Table S5).*
Likewise, we created a C-terminal HaloTag fusion to the endogenous copy of PolC. We found that this fusion was synthetically lethal with the endogenous DnaX-mYPet fusion, possibly due to an interaction between PolC and the DnaX C-terminus [19, 20]. However, we were able to introduce the DnaX-mYPet fusion at an ectopic locus (yvbJ) in combination with PolC-Halo; presumably clamp-loader complexes in this merodiploid strain contain a mix of tagged and untagged DnaX molecules, restoring viability. This strategy has been used with other PolC and DnaX fusions in previous studies [50, 51]. Growth curve measurements showed that this strain did not have a growth defect in S7_50_-sorbitol (Supplementary Fig. S4A and Supplementary Table S9), confirming functionality of the fusions. Unfortunately, we were unable to make the corresponding weak-binding PolC^QMGLF^-Halo fusion; likely the presence of the HaloTag at the PolC C-terminus in combination with the weaker CBM was too great of an impairment. We tried restoring functionality by using a longer 30 amino acid linker between the PolC C-terminus and the HaloTag, but we were still unable to recover the correct CBM mutant transformants.
Next, we validated a strategy for imaging single DnaE and PolC molecules in the cell. We used sparse labeling with low concentrations (1 nM and 500 pM, respectively) of the bright and photostable JFX_554_ dye [52] conjugated to a HaloTag ligand (Fig. 4A and B). We confirmed that the labeling procedure did not affect cell growth by comparing the change in the number of CFUs per ml in labeled versus mock-labeled cultures (Supplementary Table S10) [26]. We also verified that there was negligible detection of false positive spots in the JFX_554_ channel by labeling and imaging a strain bearing the DnaX-mYPet fusion alone (Supplementary Fig. S5).
After establishing the imaging approach, we first looked for changes in the DnaX foci or cell morphology due to DnaE CBM mutations. As a core component of the replisome, DnaX forms distinct foci at sites of replication [26, 48, 49]. In cells bearing the endogenous DnaX-mYPet fusion alone, there were typically one or two DnaX foci per cell [mean ± standard error of the mean (SEM): 1.62 ± 0.03] with average localization at quarter and three-quarter positions along the long cell axis and at midcell along the short cell axis (Supplementary Fig. S6A), in good agreement with previous results [26]. There were minimal changes (5% or less) in the number of DnaX foci per cell in cells bearing the Halo-DnaE^QMGLF(WT)^ fusion, the binding-deficient Halo-DnaE^AMGLA^ fusion, and the tight-binding Halo-DnaE^QLSLF^ fusion (Supplementary Table S7). Likewise, there were no qualitative changes in the cellular localization of the DnaX foci in these strains (Supplementary Fig. S6D–F)). We characterized cell morphology by measuring the average length and width of cells and again found only minor differences in the presence of the WT Halo-DnaE fusion or the corresponding CBM mutant fusions (Supplementary Table S11). Taken together, these results show no obvious perturbations to cell morphology or replisome positioning for the DnaE CBM mutants, consistent with our growth and replication assays.
Although the presence of the Halo-DnaE fusion appeared to have no substantial effects on DnaX or cell morphology, the PolC-Halo fusion was not as well tolerated. The cellular localization of the ectopic DnaX-mYPet fusion alone looked similar to that of the endogenous fusion (Supplementary Fig. S6B), although there was a 15% reduction in the number of foci per cell (mean ± SEM: 1.39 ± 0.03; P <.05) (Supplementary Table S11), possibly due to missed detection of dimmer foci that contain a mix of labeled and unlabeled DnaX molecules. In the presence of the PolC-Halo fusion, however, the DnaX localization shifted toward midcell along the long cell axis (Supplementary Fig. S6C); similar shifts in replisome positioning were observed previously in the presence of DNA damage [26], suggesting a mild replication defect. In addition, there were subtle changes in cell morphology, with an increase in the average cell length of ∼27% (P <.05) relative to the strain with the ectopic DnaX-mYPet fusion alone (Supplementary Table S11). Thus, simultaneous labeling of PolC and DnaX appeared to confer mild growth defects, even though growth curve measurements did not reveal any changes.
Next, we used single-particle tracking to characterize the mobility of single WT DnaE and PolC molecules in the cell by calculating an apparent diffusion coefficient (D*) from the MSD of each trajectory [26, 53]. Consistent with prior studies of DNA polymerases in B. subtilis [26] and E. coli [53, 54], we observed both static (D* ≈ 0) and mobile populations of each polymerase (Fig. 4C); the former population is expected to be bound to DNA or to DNA-bound proteins, although we cannot distinguish molecules that are synthesizing DNA from those that are not. To extract diffusion coefficients and the percentage of molecules in each population, we fit the D* distributions to a three-population model because we found that a two-population model did not fit the data well. For both DnaE and PolC, there was a static population at D* ≈ 0.08 μm^2^ s^−1^ corresponding to 18% and 19% of the total population, respectively, as well as a population with intermediate mobility (D* ≈ 0.30 μm^2^ s^−1^, 16% and 19% of the total population respectively) (Supplementary Table S12). The largest population had higher mobility, with D* ≈ 1.10 μm^2^ s^−1^ (67%) for DnaE and D* ≈ 0.88 μm^2^ s^−1^ (62%) for PolC. Consistent with this analysis, and in agreement with an alternative analysis of mobility using the Spot-On package (Supplementary Fig. S7 and Supplementary Table S13) [31], we found that the DnaE mobile population is broader and shifted to larger D* values than the PolC mobile population. DnaE molecules visually appeared more mobile in the cell, and their average cellular localization was more diffuse (Supplementary Fig. S8).
Two previous single-molecule imaging studies have characterized PolC and DnaE mobility in B. subtilis during normal growth, with partially contradictory results. One study observed similar dynamics for PolC and DnaE [51]. For both proteins, the static fraction of molecules comprised approximately half of the population; however, PolC was found to have a smaller diffusion coefficient and a shorter dwell time than DnaE, indicative of slightly faster PolC dynamics. In contrast, the other study reported that the majority of PolC molecules were statically bound, whereas DnaE molecules were moving too rapidly to track, indicative of faster DnaE dynamics [50]. Our results are not in quantitative agreement with either study, which is not unexpected due to differences in imaging and analysis parameters, although they do suggest somewhat greater DnaE mobility relative to PolC.
Having characterized the mobility of DnaE^QMGLF(WT)^ molecules, we imaged the corresponding CBM mutant fusions to determine whether altering the clamp interaction had an effect on DnaE mobility. Both the binding-deficient DnaE^AMGLA^ and tight-binding DnaE^QLSLF^ mutants had similar overall D* distributions to DnaE^QMGLF(WT)^, with similar D* values for the static and higher mobility populations (Fig. 4C and Supplementary Table S12). There was a very minor reduction in the static population for the DnaE^AMGLA^ mutant relative to DnaE^QMGLF(WT)^ (16% versus 17%), although the 95% fit confidence intervals overlapped indicating that the difference may not be statistically significant. In contrast, there was a larger increase in the static population for the DnaE^QLSLF^ mutant (21% versus 17%). Analysis results with the alternative Spot-On approach were in qualitative agreement (Supplementary Table S13). These results are consistent with a model in which DnaE is not immobilized via interactions with the clamp during normal replication, and thus the change in static population is modest for the binding-deficient mutant. However, our data indicate that DnaE is capable of interacting with the clamp when the clamp-binding interaction is strengthened, leading to an increase in static population for the tight-binding mutant.
We also asked whether the clamp interaction plays a role in enriching DnaE at the replication fork by measuring polymerase colocalization with replication sites marked by DnaX-mYPet foci. To quantify colocalization, we used radial distribution function analysis, which provides more information on intracellular colocalization than does a comparison of average cellular localization. In brief, the radial distribution function g(r) gives a measure of the fold-enrichment of DnaE or PolC as a function of distance from the closest DnaX focus relative to the apparent enrichment that would be observed by chance due to confinement in the cell [26, 54, 55]. No enrichment relative to chance corresponds to g(r) = 1 and larger values of g(r) indicate greater enrichment. Consistent with the expectation that PolC performs processive synthesis at the replication fork whereas DnaE only synthesizes short stretches of DNA, we observed moderate PolC-DnaX colocalization [maximum g(r) ≈ 2.8] and little to no DnaE-DnaX colocalization (maximum g(r) ≈ 1.3) (Fig. 4D and Supplementary Table S14). The binding-deficient DnaE^AMGLA^ mutant had a similar degree of colocalization with DnaX [maximum g(r) ≈ 1.6] as DnaE^QMGLF(WT)^. However, the tight-binding DnaE^QLSLF^ mutant showed a clear increase in colocalization with DnaX [maximum g(r) ≈ 2.9], with a maximum value of g(r) similar to that of PolC^QLSLF(WT)^. These results are consistent with the DnaE diffusion measurements, suggesting that clamp binding has little to no role in stabilizing DnaE at the replication fork in WT cells, although strengthening the clamp interaction can promote DnaE binding at the replication fork thereby increasing its access to the DNA template.
Finally, we assessed the effect of weakening the PolC CBM at the cellular level. Although we were unable to create a viable HaloTag fusion to the weak-binding PolC^QMGLF^ mutant, we found that the corresponding PolC^QMGLF^-mYPet fusion was functional (Supplementary Fig. S4C and Supplementary Table S9). Thus, we characterized the PolC-mYPet foci (Fig. 5A and B) that form at replication sites to determine the effect of the CBM mutation. First, we measured the morphology of cells bearing the PolC^QLSLF(WT)^-mYPet and PolC^QMGLF^-mYPet fusions and found that there was a ∼22% increase (P <.05) in cell length for the CBM mutant (mean ± SEM: 4.36 ± 0.04 μm) relative to WT (3.58 ± 0.04 μm) (Supplementary Table S11). Next, we measured the average number of PolC foci per cell; there was no significant difference between PolC^QLSLF(WT)^ and the PolC^QMGLF^ mutant (mean ± SEM: 1.71 ± 0.04 versus 1.78 ± 0.04; P >.05) (Supplementary Table S11). However, we found changes in the average cellular localization of PolC foci for the WT and CBM mutant (Fig. 5C). Consistent with the normal replication fork positioning observed for DnaX-mYPet foci, PolC^QLSLF(WT)^ formed foci at the quarter and three-quarter positions along the long cell axis. Conversely, the localization of PolC^QMGLF^ foci peaked at midcell along the long cell axis. As discussed previously, this change in replication fork positioning is indicative of perturbations to replication and is consistent with the defects observed in growth and replication assays for this weak-binding PolC CBM mutant.
Imaging of PolC-mYPet foci. Representative micrographs of (A) PolCQLSLF(WT)-mYPet and (B) PolCQMGLF-mYPet foci. Left: transmitted white light micrograph of B. subtilis cell with overlaid cell outline and 1-μm scale bar. Right: fluorescence micrograph of PolC-mYPet foci with overlaid centroids. (C) Average cellular localization projected along normalized long and short cell axes for PolCQLSLF(WT)-mYPet and PolCQMGLF-mYPet foci. The plotted data represent at least three independent replicates (see Supplementary Table S5).
Discussion
In this study, we investigated the role of the sliding clamp interaction in coordinating replicative polymerase activity in B. subtilis. Both PolC and DnaE contain conserved CBM sequences, and we found that the corresponding CBM peptides are capable of binding the DnaN clamp. Although the PolC CBM binds the clamp with low micromolar affinity (KD = 3.9 μM), the DnaE CBM binds very weakly (KD ≈ 78 μM). By introducing CBM mutations to the chromosomal copies of PolC and DnaE and characterizing the impact on growth and replication, we found that the DnaE–DnaN interaction is dispensable for replication in B. subtilis; either strengthening or eliminating this interaction had no effect under any conditions tested. In contrast, the PolC–DnaN interaction is essential, although it can be weakened by roughly 20-fold with modest effects on growth and replication apparent in rich media only.
Results from quantitative in vivo fluorescence microscopy are consistent with this model. We found that altering the DnaE–DnaN interaction strength has no effect on cell morphology or on the localization of the replisome marked by DnaX, consistent with our characterization of growth and replication in DnaE CBM mutant strains. However, strengthening the DnaE–DnaN interaction leads to an increase in the static, or bound, population of DnaE molecules and a modest increase in DnaE colocalization with sites of replication. These results support the idea that DnaE is capable of binding the clamp when the CBM is strengthened, consistent with our finding that there is an increase in UV-induced mutagenesis for the tight-binding DnaE^QLSLF^ mutant. In contrast, weakening the PolC–DnaN interaction strength leads to measurable changes in cell morphology and the cellular localization of replication sites.
Our results support a model in which DnaE acts distributively during replication, consistent with biochemical evidence that DnaE only adds a small number of nucleotides to the RNA primer before PolC takes over synthesis (Fig. 6) [11]. These findings are also in agreement with a previous report that DnaE is highly mobile in the cell and binds to DNA on a timescale of 10 ms or less, indicating that it can only perform a short stretch of synthesis before dissociating [50]. In this respect, there are parallels between the activity of DnaE and the eukaryotic polymerase Polα. Eukaryotes use three replicative polymerases, Pols α, δ, and ϵ [56]. Pols δ and ϵ synthesize DNA on the lagging and leading strands, respectively, whereas Pol α first synthesizes an RNA primer and then extends it by adding a short stretch of DNA. Like DnaE, Pol α lacks a proofreading 3′–5′ exonuclease and exhibits lower fidelity. There have been no reports indicating that Pol α acts in conjunction with the eukaryotic processivity factor, PCNA [57]; instead, interactions have been identified with other replisome components, including the helicase CMG [58] and the SSB protein RPA [59].
Cartoon of PolC and DnaE activity. Processive DNA synthesis by PolC via the clamp interaction for synthesis of leading and lagging strands (top) contrasted with distributive clamp-independent synthesis by DnaE for initiation of DNA synthesis of Okazaki fragments (bottom).
It is likewise possible that other protein-protein interactions play a role in coordinating DnaE activity during replication. DnaE interacts with SSB at a common binding site on the SSB C-terminal tail [21, 22]. Truncation of the SSB C-terminal tail, which is lethal in E. coli [60], is tolerated in B. subtilis, albeit with defects in replication and cell morphology [22]. DnaE foci observed in WT cells were lost in SSB C-terminal tail truncation mutants, suggesting that this interaction may play a role in replication. Because the SSB binding site on DnaE is unknown and the SSB C-terminal tail truncation mutation is pleiotropic, it is unclear whether these defects arise partially or entirely from an impairment of DnaE activity or as a consequence of perturbing the interaction of other proteins with SSB. In addition, yeast two-hybrid and gel filtration chromatography showed that DnaE forms a ternary complex with DnaC helicase and DnaG primase, consistent with a model in which this complex recruits DnaE to the lagging strand and coordinates primer handoff from DnaG to DnaE [23]. Finally, the same yeast two-hybrid study found evidence for an interaction between DnaE and the δ (HolA) subunit of the clamp-loader complex. Further investigation of these interactions will provide a more complete understanding of DnaE activity in replication in B. subtilis.
Although we have focused on B. subtilis, our results have implications for replication in other bacterial species. Phylogenetic analysis of different bacterial C-family polymerases has identified four broad categories, designated as PolC and three different DnaE subtypes (DnaE1, DnaE2, and DnaE3) [12]. Escherichia coli DnaE was assigned to the DnaE1 subtype and B. subtilis DnaE to the DnaE3 subtype. DnaE3 polymerases are never the sole replicative polymerase but are always present in combination with a PolC polymerase. The canonical CBM is almost always present and highly conserved across PolC proteins (QLSLF), and is likewise present across DnaE1 proteins, though with less conservation (QxxLF) (Supplementary Fig. S9). However, only 75% of DnaE3 proteins contain an identifiable CBM, and there is substantial variability in the first position, with only the fourth and fifth positions conserved (xxxLF); thus, B. subtilis DnaE is unusual among DnaE3 proteins in having a more canonical CBM with a glutamine in the first position. Further, glycine is the most common residue in the third position across DnaE3 proteins [12], which contrasts with the consensus aspartate or serine for all CBMs. Glycine at the third position was shown to significantly weaken clamp binding in E. coli [33], possibly due to an entropic binding penalty. Taken together with this phylogenetic analysis, our results suggest that DnaE polymerases across other bacterial species likewise do not require the clamp interaction for replication, and that the strength of the DnaE CBM may be tuned to avoid competition with PolC.
Nonetheless, our results support a model in which CBM strength alone is not the only determinant of clamp binding and polymerase selection. The viability of the weak-binding polC^QMGLF^ mutant strain indicates that a range of CBM strengths can be tolerated by replicative polymerases, although it is unclear over what affinity range. A prior study in E. coli measured the binding affinity of different Pol IIIα CBM mutants and assessed their ability to complement a temperature-sensitive Pol IIIα mutant when expressed at different levels in vivo [61]. Mutations that weakened the WT CBM (QADMF; KD = 0.8 μM) by up to 5-fold (for example, AADMF; KD = 4.2 μM) or strengthened it (QLDLF; KD ≈ 6.9 nM) were tolerated, whereas 10-fold or higher reductions in affinity (for example, QADMK; KD = 12.6 μM) were not. Conversely, the Pol IIIϵ subunit, which binds very weakly to the clamp (QTSMAF; KD = 210 μM) could be weakened by >10-fold (ϵ_Q_: ATSMAF; KD > 2 mM) or strengthened by almost 1000-fold (ϵ_L_: QLSLPL; KD = 0.38 μM) with no effect on viability, although with some effects on the DNA damage response and mutagenesis [35, 62, 63]. In this study, we observed that a 10-fold reduction in binding affinity for the polC^QMGLF^ mutant produced only modest phenotypes, suggesting that further reductions in affinity might be tolerated. An overly strong DnaE CBM could lead to replication defects if it allowed DnaE to outcompete PolC for access to the clamp. In E. coli, the interaction between Pol IIIα and the δ subunit of the clamp-loader complex helps to chaperone Pol III onto newly loaded clamps [64], but it is unknown whether a similar mechanism plays a role in polymerase selection in B. subtilis.
One surprising implication of our study is that clamp-binding interactions may be generally weaker in B. subtilis than in E. coli. Although extensive biochemical work has characterized the molecular determinants of clamp-binding in E. coli, much less is known in other bacteria. In general, the tightest CBM interactions are on the order of 200–400 nM for E. coli DnaN [17, 33]. Thus, it is surprising that a canonical CBM motif (QLSLF) binds B. subtilis DnaN with only micromolar affinity, whereas the same CBM was found to have submicromolar affinity in E. coli [17]. It is unknown whether this roughly order of magnitude difference in affinity holds for other CBM sequences in B. subtilis and, if so, whether there are functional reasons or consequences. Several other B. subtilis DNA polymerases contain highly conserved CBMs (QLxLF), including the replication and repair polymerase Pol I and the translesion polymerases Pol Y1 and Pol Y2. Although there is evidence that the Pol Y1 [26, 45] and Pol Y2 [45] CBMs are functional, the binding affinities of these sequences have not been determined in B. subtilis. Crystal structures have revealed differences in the B. subtilis DnaN binding site relative to E. coli that may contribute to weaker CBM binding in B. subtilis [34, 65], but a structure of a peptide-bound complex with B. subtilis DnaN would be necessary to draw definitive conclusions.
Finally, our study provides new insights into the role of DnaE in the DNA damage response and damage-induced mutagenesis. The observation that DnaE is modestly SOS-inducible and mutagenic suggests that it may have a role in the DNA damage response, whether through a role in repriming or by acting as a translesion polymerase to bypass DNA lesions. However, we found that altering the DnaE–DnaN interaction had no effect on cell survival upon UV or 4-NQO treatment. In E. coli, one pathway to alleviate replication stalling is repriming downstream of the lesion, and there is evidence that the replisome alone is capable of repriming without other factors [66]. Thus, if DnaE plays a role in repriming after replication stalling in B. subtilis, which seems likely given the inability of PolC to extend an RNA primer [11], this activity does not require an interaction with the clamp. Surprisingly, however, we found that strengthening the DnaE–DnaN interaction led to a moderate increase in UV-induced mutagenesis, but no change in spontaneous mutagenesis. These results are consistent with a model in which DnaE is able to gain access to DNA template via stronger clamp-binding interaction only when replication is perturbed. The lack of an effect on spontaneous mutagenesis suggests tight regulation of clamp binding at the replication fork, again consistent with the model that CBM strength is not the only determinant of polymerase selection. These results are also analogous to findings that the presence or absence of translesion polymerases only affects the damage-induced mutation rate and not the spontaneous mutation rate in both E. coli [67, 68] and B. subtilis [45, 69]. Further investigation is needed to understand the role that DnaE plays in the response to DNA damage and how its mutagenic activity is limited during normal growth.
In summary, we found that the replicative polymerase DnaE acts independently of the clamp during DNA replication in B. subtilis. In contrast, clamp binding is essential for the activity of the replicative polymerase PolC. Strengthening the interaction between DnaE and the sliding clamp promotes mutagenesis, suggesting that the relative polymerase-clamp interaction strengths may be tuned to optimize replication. Our work has implications both for replisome organization in bacteria that use more than one replicative polymerase and for genome stability in species with error-prone replicative polymerases.
Supplementary Material
gkaf721_Supplemental_File
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Johnson A, O’Donnell M Cellular DNA replicases: components and dynamics at the replication fork. J Bacteriol. 2005; 74:2153–60.10.1146/annurev.biochem.73.011303.073859.15952889 · doi ↗ · pubmed ↗
- 2Van Oijen AM, Loparo JJ Single-molecule studies of the replisome. Annu Rev Biophys. 2010; 39:429–48.10.1146/annurev.biophys.093008.131327.20462378 · doi ↗ · pubmed ↗
- 3Mc Henry CS DNA replicases from a bacterial perspective. Annu Rev Biochem. 2011; 80:403–36.10.1146/annurev-biochem-061208-091655.21675919 · doi ↗ · pubmed ↗
- 4Kong XP, Onrust R, O’Donnell M et al. Three-dimensional structure of the beta subunit of E. coli DNA polymerase III holoenzyme: a sliding DNA clamp. Cell. 1992; 69:425–37.10.1016/0092-8674(92)90445-I.1349852 · doi ↗ · pubmed ↗
- 5López de Saro FJ Regulation of interactions with sliding clamps during DNA replication and repair. Curr Genomics. 2009; 10:206–15.10.2174/138920209788185234.19881914 PMC 2705854 · doi ↗ · pubmed ↗
- 6Simonsen S, Søgaard CK, Olsen JG et al. The bacterial DNA sliding clamp, β-clamp: structure, interactions, dynamics and drug discovery. Cell Mol Life Sci. 2024; 81:24510.1007/s 00018-024-05252-w.38814467 PMC 11139829 · doi ↗ · pubmed ↗
- 7Lohman TM, Ferrari ME Escherichia coli single-stranded DNA-binding protein: multiple DNA-binding modes and cooperativities. Annu Rev Biochem. 1994; 63:527–70.10.1146/annurev.bi.63.070194.002523.7979247 · doi ↗ · pubmed ↗
- 8Shereda RD, Kozlov AG, Lohman TM et al. SSB as an organizer/mobilizer of genome maintenance complexes. Crit Rev Biochem Mol Biol. 2008; 43:289–318.10.1080/10409230802341296.18937104 PMC 2583361 · doi ↗ · pubmed ↗
